In ccRCC, the ELR+CXCL/CXCR1/2 axis promotes tumour cell proliferation and angiogenesis, mirroring observations of CKD with a similar endpoint of chronic inflammation and the development of cancer-associated fibroblasts. This evidence concerns the gene CXCR1 and cancer.